您当前所在的位置:首页 > 产品中心 > 产品详细信息
56796-20-4 分子结构
点击图片或这里关闭

(6R,7S)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

ChemBase编号:159
分子式:C15H17N7O5S3
平均质量:471.53438
单一同位素质量:471.04532968
SMILES和InChIs

SMILES:
S1[C@H]2N(C(=O)[C@@]2(OC)NC(=O)CSCC#N)C(=C(C1)CSc1n(nnn1)C)C(=O)O
Canonical SMILES:
N#CCSCC(=O)N[C@]1(OC)C(=O)N2[C@@H]1SCC(=C2C(=O)O)CSc1nnnn1C
InChI:
InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1
InChIKey:
SNBUBQHDYVFSQF-HIFRSBDPSA-N

引用这个纪录

CBID:159 http://www.chembase.cn/molecule-159.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
(6R,7S)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
IUPAC传统名
cefmetazole
cefmetazole sodium
商标名
Zefazone
别名
(6R,7S)-7-[[2-[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
SKF 83088
U 72791
U 72791a
Cefmetazole sodium
Cefmetazolo [INN-Spanish]
Cefmetazolum [INN-Latin]
Cefmetazole
CAS号
56796-20-4
PubChem SID
46504461
160963622
PubChem CID
42008

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID 价格
TRC
C242850 external link 加入购物车 请登录

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 3.3825634  质子受体 9 
质子供体 2  LogD (pH = 5.5) -2.7527611 
LogD (pH = 7.4) -4.0735326  Log P -0.6482912 
摩尔折射率 124.5707 cm3 极化性 42.419262 Å3
极化表面积 163.33 Å2 可自由旋转的化学键 9 
里宾斯基五规则 true 
Log P -0.38  LOG S -2.34 
溶解度 2.16e+00 g/l 

分子性质

分子性质

理化性质 安全信息 产品相关信息 生物活性(PubChem)
溶解度
94.2 mg/L expand 查看数据来源
Acetone expand 查看数据来源
Methanol expand 查看数据来源
Water expand 查看数据来源
外观
White Solid expand 查看数据来源
熔点
163-165°C expand 查看数据来源
疏水性(logP)
-2.2 expand 查看数据来源
保存条件
-20°C Freezer expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
质检报告
下载链接 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank TRC TRC
DrugBank -  DB00274 external link
Item Information
Drug Groups approved
Description A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. [PubChem]
Indication For the treatment of infections caused by susceptible organisms.
Pharmacology Cefmetazole is a second-generation cephalosporin. The cephalosporins are bactericidal drugs with both gram-positive and gram-negative activity. They inhibit bacterial cell wall synthesis in a way similar to the penicillins. Cefmetazole is more active than 1st-generation cephalosporins against indole-positive Proteus, Serratia, anaerobic gram-negative bacilli (including B. fragilis), and some E. coli, Klebsiella, and P. mirabilis, but is less active than cefoxitin or cefotetan against most gram-negative bacilli.
Toxicity Oral LD50 in rats is 3,204 mg/kg. With other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions.
Affected Organisms
• Enteric bacteria and other eubacteria
Biotransformation No appreciable metabolism.
Absorption Bioavailability is approximately 100% following intramuscular injection.
Half Life 1.50 ±0.14 hours
External Links
• Wikipedia
Toronto Research Chemicals -  C242850 external link
Semi-synthetic antibiotic derived from Cephamycin. Antibacterial.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Nakao, H., et al.: J. Antibiot., 29, 554 (1976)
  • Iwata, M., et al.: Jpn. J. Exp. Med., 48, 401 (1976)
  • Shindo, H., et al.: Chemoterapy, 27, 64 (1976)
  • Nishida, M., et al.: J. Antibiot., 32, 1319 (1976)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle